Do you want to read an article? Please log in or register.
EFFECTIVENESS OF DIFLUPREDNATE FOR THE TREATMENT OF ANTERIOR SCLERITIS
Further Publications
Related content
Further Publications
Remission Of Non-Infectious Anterior Scleritis: Incidence And Predictive Factors
Am J Ophthalmol.
Kempen JH, Pistilli M, Begum H, Fitzgerald TD, Liesegang TL, Payal A, Zebardast N, Bhatt NP, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE
doi: 10.1016/j.ajo.
Macular DiseasesUveitis
The effect of methotrexate and sulfasalazine on the course of HLA-B27-positive anterior uveitis: results from a retrospective cohort study
Graefes Arch Clin Exp Ophthalmol.
Zu Hoerste MM, Walscheid K, Tappeiner C, Zurek-Imhoff B, Heinz C, Heiligenhaus A
doi: 10.1007/s00417-018-4082-x.
Glaucoma and Ocular PressureOcular Oncology
Intraocular Pressure Lowering Effect of Latanoprost as First-line Treatment for Glaucoma
J Glaucoma.
Aspberg J, Heijl A, Jóhannesson G, Lindén C, Andersson S, Bengtsson B
doi: 10.1097/IJG.
Uveitis
Review for Disease of the Year: Treatment of Viral Anterior Uveitis: A Perspective
Ocul Immunol Inflamm.
Zandi S, Bodaghi B, Garweg JG
doi: 10.1080/09273948.
Uveitis
Treatment of chronic non-infectious uveitis and scleritis
Swiss Med Wkly.
Rossi DC, Ribi C, Guex-Crosier Y
doi: 10.4414/smw.2019.20025.
Surgery and Intervention
Interface infectious keratitis after anterior and posterior lamellar keratoplasty. Clinical features and treatment strategies. A review
Br J Ophthalmol.
Fontana L, Moramarco A, Mandarà E, Russello G, Iovieno A
doi: 10.1136/bjophthalmol-2018-312938.
Macular Diseases
A systematic review on the quality, validity and usefulness of current cost-effectiveness studies for treatments of neovascular age-related macular degeneration
Acta Ophthalmol.
Elshout M, Webers CAB, van der Reis MI, Schouten JSAG
doi: 10.1111/aos.13824.
Uveitis
Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial
JAMA.
Rathinam SR, Gonzales JA, Thundikandy R, Kanakath A, Murugan SB, Vedhanayaki R, Lim LL, Suhler EB, Al-Dhibi HA, Doan T, Keenan JD, Rao MM, Ebert CD, Nguyen HH, Kim E, Porco TC, Acharya NR, FAST Research Group.
doi: 10.1001/jama.2019.12618.
COMMENTED
Further Publications
Age effect on treatment responses to 0.05%, 0.025%, and 0.01% atropine: Low-concentration Atropine for Myopia Progression (LAMP) Study
★ 3
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
★ 1
Recommended by
Prof. Dr emer. Josef Flammer, Faculty Member
Ophthalmology
Li FF, Zhang Y, Zhang X, Kei Yip BH, Tang SM, Kam KW, Young AL, Chen LJ, Tham CC, Pang CP, Yam JC
doi: 10.1016/j.ophtha.2020.12.036